Trial Profile
A phase 2 randomized, double blind, placebo-controlled trial of iPPS for synovial biomarkers in knee osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jan 2024
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- Acronyms PARA-OA008
- 15 Nov 2023 Results assessing clinical and disease modifying biomarker and structural changes in subjects with knee OA pain treated with injectable pentosan polysulfate sodium presented at the ACR Convergence 2023
- 15 Apr 2023 According to a Paradigm Biopharmaceuticals media release, the study was not powered for statistical significance and a 12-month data analysis will be released at the end of 2023
- 14 Apr 2023 New trial record